— Know what they know.
Not Investment Advice

AMPH NASDAQ

Amphastar Pharmaceuticals, Inc.
1W: +5.0% 1M: -13.5% 3M: -36.4% YTD: -31.4% 1Y: -27.6% 3Y: -57.7% 5Y: -9.1%
$18.41
+0.25 (+1.38%)
 
Weekly Expected Move ±12.5%
$13 $15 $17 $19 $21
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 30 · $811.8M mcap · 33M float · 1.89% daily turnover · Short 52% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 7.7%  ·  5Y Avg: 24.4%
Cost Advantage ★
61
Intangibles
30
Switching Cost
42
Network Effect
28
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AMPH shows a Weak competitive edge (41.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 7.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$19
Low
$20
Avg Target
$21
High
Based on 2 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$20.67
Analysts3
Consensus Change History
DateFieldFromTo
2026-04-25 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-14 Wells Fargo Benjamin Burnett Initiated $19 +3.7% $18.32
2026-05-11 Piper Sandler $32 $21 -11 +10.5% $19.00
2026-04-20 Jefferies Dennis Ding Initiated $22 -4.0% $22.92
2025-12-08 Barclays Initiated $30 +15.3% $26.01
2025-03-21 Piper Sandler David Amsellem $66 $32 -34 +13.1% $28.29
2024-08-08 Piper Sandler David Amsellem $71 $66 -5 +52.4% $43.30
2024-05-23 Piper Sandler David Amsellem $35 $71 +36 +63.9% $43.31
2022-03-11 Piper Sandler David Amsellem Initiated $35 +2.0% $34.30

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
5
ROE
4
ROA
4
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AMPH receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (4/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-05-12 A A-
2026-05-08 A- A
2026-05-04 A A-
2026-04-01 B+ A
2026-03-30 A- B+
2026-03-05 A A-
2026-02-27 C A
2026-02-26 B+ C
2026-02-09 A- B+
2026-02-06 B+ A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

47 Grade B
Profitability
33
Balance Sheet
68
Earnings Quality
69
Growth
20
Value
83
Momentum
54
Safety
50
Cash Flow
61
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AMPH scores highest in Value (83/100) and lowest in Growth (20/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.27
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.63
Unlikely Manipulator
Ohlson O-Score
-7.58
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 58.2/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 2.13x
Accruals: -5.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AMPH scores 2.27, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AMPH scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AMPH's score of -2.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AMPH's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AMPH receives an estimated rating of BBB (score: 58.2/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AMPH's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
10.53x
PEG
-0.25x
P/S
1.13x
P/B
1.08x
P/FCF
6.73x
P/OCF
5.39x
EV/EBITDA
8.23x
EV/Revenue
1.78x
EV/EBIT
10.22x
EV/FCF
9.49x
Earnings Yield
8.71%
FCF Yield
14.85%
Shareholder Yield
4.29%
Graham Number
$25.52
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 10.5x earnings, AMPH trades at a reasonable valuation. An earnings yield of 8.7% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $25.52 per share, suggesting a potential 39% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.771
NI / EBT
×
Interest Burden
0.819
EBT / EBIT
×
EBIT Margin
0.174
EBIT / Rev
×
Asset Turnover
0.449
Rev / Assets
×
Equity Multiplier
2.108
Assets / Equity
=
ROE
10.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AMPH's ROE of 10.4% is driven by Asset Turnover (0.449), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$14.50
Price/Value
1.35x
Margin of Safety
-35.14%
Premium
35.14%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AMPH's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. AMPH trades at a 35% premium to its adjusted intrinsic value of $14.50, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 10.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$18.41
Median 1Y
$16.52
5th Pctile
$8.16
95th Pctile
$33.47
Ann. Volatility
43.1%
Analyst Target
$20.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jack Yongfeng Zhang
Chief Executive Officer, President, Chief Scientific Officer
$950,911 $3,301,981 $8,309,350
Mary Ziping Luo
Chief Operating Officer, Chief Scientist and Chairman
$775,120 $1,391,976 $4,031,078
William J. Peters
Chief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director
$649,846 $1,043,982 $3,238,682
Rong Zhou
Senior Executive Vice President of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd
$717,587 $701,500 $2,542,634
Jacob Liawatidewi
Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S.
$499,909 $591,979 $2,037,856

CEO Pay Ratio

126:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $8,309,350
Avg Employee Cost (SGA/emp): $65,693
Employees: 1,976

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,976
-2.6% YoY
Revenue / Employee
$364,315
Rev: $719,887,000
Profit / Employee
$49,643
NI: $98,094,000
SGA / Employee
$65,693
Avg labor cost proxy
R&D / Employee
$43,443
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 2.7% 9.2% 14.7% 19.2% 21.4% 18.2% 18.8% 19.1% 20.9% 27.8% 23.6% 26.5% 28.5% 27.0% 23.3% 20.6% 19.6% 16.3% 12.9% 10.4% 10.42%
ROA 1.7% 5.9% 9.5% 12.5% 14.0% 11.9% 12.9% 13.2% 14.4% 19.1% 12.2% 13.7% 14.8% 14.0% 10.3% 9.2% 8.7% 7.2% 6.1% 4.9% 4.94%
ROIC 4.4% 10.0% 12.7% 15.3% 18.4% 17.4% 18.8% 20.5% 22.8% 31.6% 15.9% 17.7% 18.9% 18.0% 14.9% 13.7% 13.0% 10.6% 9.6% 7.7% 7.74%
ROCE 3.9% 9.8% 15.0% 19.2% 20.9% 18.2% 18.2% 18.9% 20.9% 29.3% 15.4% 16.5% 18.3% 16.5% 15.1% 14.3% 13.4% 11.5% 10.1% 8.5% 8.54%
Gross Margin 46.6% 45.6% 46.5% 46.4% 51.3% 48.7% 52.7% 52.7% 49.9% 60.0% 54.0% 50.8% 52.2% 54.0% 46.5% 50.0% 49.6% 51.4% 46.8% 41.1% 41.08%
Operating Margin 10.4% 22.1% 20.1% 18.0% 20.1% 19.3% 28.0% 23.9% 25.3% 40.3% 30.3% 27.9% 30.3% 30.2% 24.2% 21.9% 24.2% 13.2% 19.4% 8.0% 7.96%
Net Margin 7.6% 26.3% 16.3% 20.1% 14.0% 13.2% 25.1% 18.6% 17.9% 27.3% 20.3% 25.1% 20.8% 21.4% 20.4% 14.8% 17.8% 9.0% 13.3% 3.8% 3.75%
EBITDA Margin 20.8% 39.8% 28.0% 30.1% 24.6% 25.4% 36.5% 29.5% 29.8% 50.4% 36.3% 36.1% 40.0% 36.4% 34.9% 30.7% 35.5% 21.9% 21.1% 8.0% 7.96%
FCF Margin 13.6% 10.8% 16.1% 22.0% 14.8% 18.5% 13.1% 9.9% 18.6% 23.3% 22.6% 23.8% 25.0% 23.6% 23.6% 20.6% 15.6% 15.7% 16.8% 18.8% 18.76%
OCF Margin 21.0% 18.0% 22.4% 27.7% 20.3% 23.6% 17.9% 15.2% 24.2% 29.1% 28.5% 29.3% 29.8% 28.9% 29.2% 26.5% 22.2% 21.1% 21.7% 23.4% 23.44%
ROE 3Y Avg snapshot only 17.86%
ROE 5Y Avg snapshot only 17.89%
ROA 3Y Avg snapshot only 8.02%
ROIC 3Y Avg snapshot only 15.26%
ROIC Economic snapshot only 6.29%
Cash ROA snapshot only 10.37%
Cash ROIC snapshot only 14.53%
CROIC snapshot only 11.63%
NOPAT Margin snapshot only 12.49%
Pretax Margin snapshot only 14.27%
R&D / Revenue snapshot only 12.84%
SGA / Revenue snapshot only 18.31%
SBC / Revenue snapshot only 3.91%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 95.56 26.35 18.77 22.94 20.37 19.21 15.86 20.92 29.94 18.33 23.84 15.05 12.50 15.96 12.12 10.21 8.20 11.38 12.88 11.49 10.531
P/S Ratio 2.60 2.30 2.66 4.10 3.88 3.06 2.90 3.76 5.64 4.12 5.09 3.44 2.92 3.49 2.65 1.99 1.53 1.76 1.75 1.26 1.127
P/B Ratio 2.48 2.36 2.62 4.19 4.16 3.33 2.74 3.69 5.77 4.69 5.13 3.64 3.26 3.94 2.64 1.98 1.51 1.74 1.60 1.15 1.079
P/FCF 19.08 21.34 16.53 18.67 26.31 16.52 22.24 37.90 30.38 17.73 22.56 14.46 11.69 14.79 11.22 9.63 9.85 11.22 10.42 6.73 6.732
P/OCF 12.38 12.77 11.90 14.82 19.17 12.97 16.25 24.73 23.31 14.18 17.87 11.73 9.79 12.09 9.06 7.49 6.92 8.34 8.09 5.39 5.389
EV/EBITDA 20.33 11.69 10.14 13.49 12.54 11.08 9.41 12.38 18.11 10.70 15.17 10.33 8.43 10.75 8.79 7.23 6.18 7.68 8.40 8.23 8.229
EV/Revenue 2.50 2.21 2.59 4.03 3.82 2.99 2.76 3.62 5.51 4.00 5.66 3.98 3.43 4.00 3.24 2.57 2.13 2.35 2.27 1.78 1.781
EV/EBIT 47.74 17.87 13.34 16.80 15.36 14.03 11.67 15.32 22.01 12.70 18.36 12.68 10.42 13.60 11.16 9.34 8.18 10.56 10.97 10.22 10.218
EV/FCF 18.34 20.48 16.07 18.35 25.85 16.16 21.12 36.47 29.65 17.21 25.08 16.74 13.75 16.95 13.70 12.48 13.67 15.01 13.50 9.49 9.493
Earnings Yield 1.0% 3.8% 5.3% 4.4% 4.9% 5.2% 6.3% 4.8% 3.3% 5.5% 4.2% 6.6% 8.0% 6.3% 8.3% 9.8% 12.2% 8.8% 7.8% 8.7% 8.71%
FCF Yield 5.2% 4.7% 6.1% 5.4% 3.8% 6.1% 4.5% 2.6% 3.3% 5.6% 4.4% 6.9% 8.6% 6.8% 8.9% 10.4% 10.2% 8.9% 9.6% 14.9% 14.85%
Price/Tangible Book snapshot only 4.084
EV/OCF snapshot only 7.599
EV/Gross Profit snapshot only 3.762
Acquirers Multiple snapshot only 10.993
Shareholder Yield snapshot only 4.29%
Graham Number snapshot only $25.52
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.49 2.49 3.06 3.06 3.06 3.06 3.99 3.99 3.99 3.99 2.17 2.17 2.17 2.17 3.07 3.07 3.07 3.07 4.02 4.02 4.021
Quick Ratio 1.63 1.63 2.17 2.17 2.17 2.17 2.90 2.90 2.90 2.90 1.70 1.70 1.70 1.70 2.19 2.19 2.19 2.19 2.90 2.90 2.903
Debt/Equity 0.17 0.17 0.23 0.23 0.23 0.23 0.19 0.19 0.19 0.19 0.98 0.98 0.98 0.98 0.89 0.89 0.89 0.89 0.83 0.83 0.832
Net Debt/Equity -0.10 -0.10 -0.07 -0.07 -0.07 -0.07 -0.14 -0.14 -0.14 -0.14 0.57 0.57 0.57 0.57 0.59 0.59 0.59 0.59 0.47 0.47 0.473
Debt/Assets 0.11 0.11 0.16 0.16 0.16 0.16 0.14 0.14 0.14 0.14 0.41 0.41 0.41 0.41 0.41 0.41 0.41 0.41 0.40 0.40 0.403
Debt/EBITDA 1.42 0.86 0.94 0.77 0.72 0.80 0.70 0.68 0.62 0.46 2.60 2.39 2.15 2.32 2.42 2.51 2.62 2.94 3.37 4.21 4.206
Net Debt/EBITDA -0.81 -0.49 -0.29 -0.24 -0.22 -0.24 -0.50 -0.48 -0.44 -0.33 1.53 1.41 1.26 1.37 1.60 1.65 1.73 1.94 1.92 2.39 2.393
Interest Coverage 44.42 63.40 96.07 96.12 81.85 69.60 63.86 64.83 26.57 10.40 7.31 6.01 5.82 6.35 6.97 7.17 7.30 6.37 5.85 4.88 4.878
Equity Multiplier 1.57 1.57 1.51 1.51 1.51 1.51 1.40 1.40 1.40 1.40 2.37 2.37 2.37 2.37 2.15 2.15 2.15 2.15 2.07 2.07 2.066
Cash Ratio snapshot only 1.788
Debt Service Coverage snapshot only 6.057
Cash to Debt snapshot only 0.431
FCF to Debt snapshot only 0.206
Defensive Interval snapshot only 693.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.63 0.68 0.67 0.70 0.73 0.74 0.71 0.73 0.77 0.85 0.57 0.60 0.63 0.64 0.47 0.47 0.47 0.47 0.45 0.45 0.449
Inventory Turnover 2.11 2.24 2.51 2.58 2.64 2.65 2.55 2.56 2.69 2.80 2.80 2.98 3.11 3.25 2.76 2.77 2.77 2.82 2.20 2.30 2.295
Receivables Turnover 6.90 7.41 6.05 6.29 6.59 6.70 5.95 6.19 6.45 7.18 6.33 6.64 7.00 7.08 5.81 5.80 5.73 5.76 5.14 5.15 5.149
Payables Turnover 8.84 9.41 10.22 10.50 10.75 10.78 11.71 11.79 12.39 12.88 12.77 13.57 14.19 14.83 12.82 12.84 12.87 13.09 11.53 12.02 12.024
DSO 53 49 60 58 55 55 61 59 57 51 58 55 52 52 63 63 64 63 71 71 70.9 days
DIO 173 163 145 142 138 138 143 142 135 130 130 123 117 112 132 132 132 129 166 159 159.0 days
DPO 41 39 36 35 34 34 31 31 29 28 29 27 26 25 28 28 28 28 32 30 30.4 days
Cash Conversion Cycle 185 173 170 165 160 159 173 170 163 153 159 151 144 139 166 166 167 165 205 200 199.6 days
Fixed Asset Turnover snapshot only 2.037
Operating Cycle snapshot only 229.9 days
Cash Velocity snapshot only 2.548
Capital Intensity snapshot only 2.261
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 15.0% 22.4% 25.1% 23.6% 24.2% 17.5% 14.0% 14.0% 13.4% 24.0% 29.1% 30.4% 31.8% 19.9% 13.2% 7.7% 1.0% 0.3% -1.3% -1.1% -1.06%
Net Income 1.6% 4.4% 43.3% 31.6% 7.7% 1.1% 47.1% 14.6% 12.1% 75.2% 50.5% 66.0% 63.3% 16.6% 16.0% -8.4% -19.1% -29.2% -38.5% -44.1% -44.06%
EPS 1.4% 4.4% 41.0% 30.1% 7.1% 1.0% 42.4% 14.6% 12.4% 71.5% 46.8% 62.8% 66.7% 21.2% 18.1% -2.7% -12.5% -23.0% -32.1% -39.9% -39.93%
FCF 5.9% 2.4% 2.0% 1.2% 34.4% 1.0% -7.6% -48.6% 42.7% 55.7% 1.2% 2.1% 77.3% 21.7% 18.6% -6.7% -37.0% -33.4% -29.7% -10.0% -10.01%
EBITDA 54.0% 1.1% 2.7% 3.5% 2.1% 67.8% 30.9% 11.4% 13.4% 71.8% 64.3% 72.3% 76.6% 19.3% 11.9% -0.6% -14.6% -17.6% -27.6% -39.8% -39.84%
Op. Income 3.1% 5.2% 5.4% 4.9% 2.5% 93.6% 53.8% 46.9% 37.6% 92.6% 83.2% 77.3% 75.0% 18.5% 4.3% -8.0% -21.0% -30.0% -31.7% -40.0% -40.04%
OCF Growth snapshot only -12.58%
Asset Growth snapshot only 3.29%
Equity Growth snapshot only 7.72%
Debt Growth snapshot only 0.84%
Shares Change snapshot only -6.88%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 15.7% 15.9% 14.1% 12.9% 13.7% 13.8% 15.7% 16.6% 17.4% 21.3% 22.6% 22.5% 22.9% 20.4% 18.6% 17.0% 14.7% 14.3% 13.0% 11.6% 11.58%
Revenue 5Y 7.4% 9.0% 11.4% 12.5% 13.8% 14.8% 15.7% 16.5% 16.9% 17.8% 16.9% 16.4% 17.1% 17.0% 17.7% 17.3% 16.6% 16.5% 15.5% 14.4% 14.37%
EPS 3Y 2.2% 17.2% 12.2% 19.1% 18.5% 1.8% 1.7% 3.4% 2.9% 1.5% 61.5% 35.2% 22.0% 17.9% 17.0% 5.6% -1.6% -1.65%
EPS 5Y -7.0% 10.7% 40.3% 53.1% 82.7% 2.0% 80.8% 1.3% 24.7% 24.1% 24.0% 21.4% 1.0% 77.4% 1.3% 1.0% 1.02%
Net Income 3Y 2.3% 19.8% 14.2% 23.1% 21.4% 1.9% 1.7% 3.6% 3.0% 1.5% 63.5% 36.9% 20.3% 14.0% 13.1% 2.4% -5.3% -5.26%
Net Income 5Y -5.6% 11.6% 42.6% 55.5% 86.6% 2.0% 82.5% 1.3% 25.8% 24.9% 26.7% 22.2% 1.0% 75.8% 1.3% 99.7% 99.69%
EBITDA 3Y 6.5% 1.5% 1.4% 1.1% 92.5% 83.5% 87.7% 66.3% 75.0% 82.6% 99.7% 1.0% 83.2% 51.0% 34.0% 24.0% 19.6% 19.1% 10.0% 1.0% 0.98%
EBITDA 5Y 3.9% 9.8% 29.5% 39.9% 50.8% 63.4% 57.8% 83.5% 3.3% 1.2% 98.8% 80.2% 70.2% 66.2% 64.8% 51.1% 51.9% 43.0% 45.2% 38.6% 38.56%
Gross Profit 3Y 25.2% 24.7% 23.1% 20.3% 21.2% 20.6% 23.6% 24.6% 25.8% 32.6% 34.8% 34.0% 32.7% 28.3% 22.9% 20.6% 16.7% 15.1% 12.7% 8.5% 8.53%
Gross Profit 5Y 9.1% 9.0% 13.9% 15.6% 18.5% 21.0% 22.3% 25.7% 26.8% 28.5% 26.8% 24.7% 24.9% 23.4% 23.0% 21.8% 21.1% 20.6% 20.0% 17.6% 17.63%
Op. Income 3Y 2.7% 2.8% 1.2% 1.7% 1.8% 1.6% 1.5% 1.0% 64.1% 43.2% 33.8% 23.9% 16.9% 9.3% -0.7% -0.72%
Op. Income 5Y 1.7% 7.0% 34.8% 44.2% 81.3% 1.6% 1.6% 78.9% 93.4% 80.5% 66.6% 53.3% 53.32%
FCF 3Y 38.1% 2.1% 5.8% 61.6% 1.2% 83.8% 52.8% 50.4% 56.3% 34.7% 14.5% 16.8% 8.0% 23.0% 38.0% 38.01%
FCF 5Y 33.6% 42.1% 32.6% 35.0% 33.4% 46.9% 73.8% 46.1% 1.3% 2.8% 65.3% 54.0% 38.9% 24.5% 24.53%
OCF 3Y 47.5% 24.6% 36.9% 68.7% 9.6% 35.9% 28.8% 18.9% 73.2% 56.0% 47.4% 36.2% 38.1% 40.9% 29.6% 15.3% 18.2% 10.0% 20.5% 28.9% 28.93%
OCF 5Y 21.8% 21.7% 20.5% 21.8% 18.0% 21.4% 17.9% 25.6% 39.1% 35.4% 36.9% 49.9% 23.7% 35.5% 38.6% 32.8% 44.6% 27.0% 22.2% 16.5% 16.52%
Assets 3Y 11.6% 11.6% 9.4% 9.4% 9.4% 9.4% 8.1% 8.1% 8.1% 8.1% 33.8% 33.8% 33.8% 33.8% 32.9% 32.9% 32.9% 32.9% 30.0% 30.0% 29.98%
Assets 5Y 10.1% 10.1% 9.4% 9.4% 9.4% 9.4% 10.3% 10.3% 10.3% 10.3% 24.1% 24.1% 24.1% 24.1% 21.9% 21.9% 21.9% 21.9% 20.9% 20.9% 20.88%
Equity 3Y 6.0% 6.0% 10.3% 10.3% 10.3% 10.3% 11.5% 11.5% 11.5% 11.5% 16.7% 16.7% 16.7% 16.7% 18.0% 18.0% 18.0% 18.0% 14.3% 14.3% 14.27%
Book Value 3Y 3.9% 4.8% 9.6% 9.1% 7.9% 8.3% 7.9% 8.8% 6.9% 8.6% 12.5% 14.1% 14.8% 15.3% 16.5% 19.6% 22.0% 22.1% 17.8% 18.6% 18.62%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.74 0.80 0.88 0.91 0.92 0.95 0.96 0.97 0.97 0.95 0.91 0.89 0.89 0.94 0.96 0.97 0.95 0.96 0.94 0.92 0.918
Earnings Stability 0.01 0.13 0.33 0.44 0.38 0.57 0.64 0.69 0.58 0.71 0.79 0.78 0.67 0.76 0.82 0.75 0.85 0.75 0.61 0.38 0.381
Margin Stability 0.91 0.91 0.92 0.93 0.92 0.90 0.89 0.86 0.85 0.84 0.84 0.86 0.87 0.88 0.89 0.90 0.90 0.90 0.90 0.90 0.899
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.81 0.94 0.95 0.50 0.50 0.50 0.50 0.93 0.94 0.97 0.92 0.88 0.85 0.82 0.824
Earnings Smoothness 0.12 0.00 0.00 0.00 0.00 0.27 0.62 0.86 0.89 0.45 0.60 0.50 0.52 0.85 0.85 0.91 0.79 0.66 0.52 0.43 0.435
ROE Trend -0.06 0.00 0.07 0.11 0.19 0.12 0.10 0.08 0.08 0.12 0.06 0.06 0.06 0.03 0.02 -0.02 -0.04 -0.10 -0.09 -0.12 -0.117
Gross Margin Trend 0.03 0.03 0.05 0.05 0.05 0.06 0.07 0.08 0.06 0.08 0.07 0.05 0.05 0.02 -0.01 -0.02 -0.03 -0.04 -0.03 -0.05 -0.049
FCF Margin Trend 0.11 0.08 0.13 0.14 0.10 0.11 0.02 -0.07 0.04 0.09 0.08 0.08 0.08 0.03 0.06 0.04 -0.06 -0.08 -0.06 -0.03 -0.035
Sustainable Growth Rate 2.7% 9.2% 14.7% 19.2% 21.4% 18.2% 18.8% 19.1% 20.9% 27.8% 23.6% 26.5% 28.5% 27.0% 23.3% 20.6% 19.6% 16.3% 12.9% 10.4% 10.42%
Internal Growth Rate 1.7% 6.3% 10.5% 14.3% 16.2% 13.5% 14.9% 15.2% 16.9% 23.7% 13.9% 15.9% 17.3% 16.3% 11.5% 10.1% 9.6% 7.8% 6.5% 5.2% 5.20%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 7.72 2.06 1.58 1.55 1.06 1.48 0.98 0.85 1.28 1.29 1.33 1.28 1.28 1.32 1.34 1.36 1.19 1.36 1.59 2.13 2.132
FCF/OCF 0.65 0.60 0.72 0.79 0.73 0.78 0.73 0.65 0.77 0.80 0.79 0.81 0.84 0.82 0.81 0.78 0.70 0.74 0.78 0.80 0.800
FCF/Net Income snapshot only 1.706
OCF/EBITDA snapshot only 1.083
CapEx/Revenue 7.4% 7.2% 6.3% 5.7% 5.5% 5.1% 4.8% 5.3% 5.6% 5.8% 5.9% 5.5% 4.8% 5.3% 5.6% 5.9% 6.6% 5.4% 4.8% 4.7% 4.68%
CapEx/Depreciation snapshot only 1.109
Accruals Ratio -0.12 -0.06 -0.06 -0.07 -0.01 -0.06 0.00 0.02 -0.04 -0.06 -0.04 -0.04 -0.04 -0.04 -0.03 -0.03 -0.02 -0.03 -0.04 -0.06 -0.056
Sloan Accruals snapshot only 0.054
Cash Flow Adequacy snapshot only 5.012
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.6% 52.2% 46.5% 32.4% 29.6% 45.7% 43.7% 50.1% 39.9% 56.3% 42.3% 43.6% 45.5% 38.5% 64.4% 68.1% 94.4% 37.6% 20.9% 49.2% 49.23%
Div. Increase Streak
Chowder Number
Buyback Yield 1.7% 2.0% 2.5% 1.4% 1.5% 2.4% 2.8% 2.4% 1.3% 3.1% 1.8% 2.9% 3.6% 2.4% 5.3% 6.7% 11.5% 3.3% 1.6% 4.3% 4.29%
Net Buyback Yield 1.7% 2.0% 2.5% 1.4% 1.5% 2.4% 2.8% 2.4% 1.3% 3.1% 1.7% 2.7% 3.2% 2.0% 5.0% 6.3% 11.5% 3.3% 1.5% 4.1% 4.07%
Total Shareholder Return 1.7% 2.0% 2.5% 1.4% 1.5% 2.4% 2.8% 2.4% 1.3% 3.1% 1.7% 2.7% 3.2% 2.0% 5.0% 6.3% 11.5% 3.3% 1.5% 4.1% 4.07%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.53 0.72 0.74 0.76 0.78 0.77 0.80 0.78 0.79 0.80 0.81 0.84 0.83 0.85 0.84 0.82 0.83 0.82 0.79 0.77 0.771
Interest Burden (EBT/EBIT) 0.98 0.98 0.99 0.98 0.98 0.97 0.97 0.97 0.95 0.90 0.85 0.87 0.86 0.88 0.89 0.86 0.86 0.84 0.83 0.82 0.819
EBIT Margin 0.05 0.12 0.19 0.24 0.25 0.21 0.24 0.24 0.25 0.32 0.31 0.31 0.33 0.29 0.29 0.28 0.26 0.22 0.21 0.17 0.174
Asset Turnover 0.63 0.68 0.67 0.70 0.73 0.74 0.71 0.73 0.77 0.85 0.57 0.60 0.63 0.64 0.47 0.47 0.47 0.47 0.45 0.45 0.449
Equity Multiplier 1.55 1.55 1.54 1.54 1.54 1.54 1.45 1.45 1.45 1.45 1.93 1.93 1.93 1.93 2.25 2.25 2.25 2.25 2.11 2.11 2.108
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.21 $0.72 $1.24 $1.56 $1.71 $1.46 $1.77 $1.79 $1.92 $2.51 $2.59 $2.92 $3.20 $3.04 $3.06 $2.84 $2.80 $2.34 $2.08 $1.71 $1.71
Book Value/Share $8.12 $8.04 $8.90 $8.57 $8.37 $8.44 $10.22 $10.17 $9.96 $9.80 $12.06 $12.06 $12.29 $12.33 $14.07 $14.68 $15.22 $15.36 $16.72 $16.98 $17.06
Tangible Book/Share $7.30 $7.23 $8.12 $7.82 $7.64 $7.70 $9.50 $9.45 $9.25 $9.11 $0.49 $0.49 $0.50 $0.50 $2.72 $2.84 $2.94 $2.97 $4.72 $4.80 $4.80
Revenue/Share $7.75 $8.25 $8.75 $8.76 $8.96 $9.18 $9.65 $9.98 $10.19 $11.15 $12.16 $12.76 $13.70 $13.91 $14.01 $14.60 $14.97 $15.17 $15.26 $15.51 $15.90
FCF/Share $1.06 $0.89 $1.41 $1.92 $1.32 $1.70 $1.26 $0.99 $1.89 $2.59 $2.74 $3.04 $3.42 $3.28 $3.31 $3.01 $2.33 $2.38 $2.57 $2.91 $2.98
OCF/Share $1.63 $1.49 $1.96 $2.42 $1.81 $2.17 $1.72 $1.52 $2.47 $3.24 $3.46 $3.74 $4.08 $4.02 $4.10 $3.87 $3.32 $3.19 $3.31 $3.64 $3.73
Cash/Share $2.13 $2.11 $2.73 $2.63 $2.57 $2.59 $3.40 $3.38 $3.31 $3.26 $4.84 $4.84 $4.93 $4.95 $4.26 $4.44 $4.61 $4.65 $6.00 $6.09 $6.50
EBITDA/Share $0.95 $1.56 $2.23 $2.61 $2.73 $2.48 $2.83 $2.91 $3.10 $4.17 $4.53 $4.92 $5.58 $5.17 $5.16 $5.20 $5.15 $4.64 $4.13 $3.36 $3.36
Debt/Share $1.36 $1.35 $2.09 $2.01 $1.97 $1.98 $1.98 $1.97 $1.93 $1.90 $11.76 $11.76 $11.98 $12.03 $12.50 $13.04 $13.52 $13.64 $13.91 $14.12 $14.12
Net Debt/Share $-0.77 $-0.77 $-0.64 $-0.62 $-0.60 $-0.61 $-1.42 $-1.41 $-1.38 $-1.36 $6.92 $6.92 $7.05 $7.07 $8.24 $8.60 $8.91 $9.00 $7.91 $8.03 $8.03
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.271
Altman Z-Prime snapshot only 4.913
Piotroski F-Score 7 7 8 8 8 8 7 8 8 8 5 5 7 5 8 7 6 6 7 6 6
Beneish M-Score -2.72 -2.40 -2.54 -2.56 -2.28 -2.55 -2.34 -2.26 -2.46 -2.50 -1.19 -1.16 -1.20 -1.17 -2.39 -2.47 -2.37 -2.60 -2.68 -2.63 -2.634
Ohlson O-Score snapshot only -7.579
ROIC (Greenblatt) snapshot only 15.10%
Net-Net WC snapshot only $-4.40
EVA snapshot only $-26239052.40
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 94.16 95.58 95.70 95.49 95.92 95.56 96.32 95.36 95.54 93.04 79.52 74.44 74.20 73.91 75.67 73.39 67.01 64.32 68.24 58.23 58.229
Credit Grade snapshot only 9
Credit Trend snapshot only -15.158
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 47
Sector Credit Rank snapshot only 52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms